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Abstract
We investigated the genotoxic responses to two types of TiOz nanoparticles «Z5 nm anatase: TiOz-An, and <100 nm rutile:
TiOz-Ru) in human hepatoma HepGZ cells. Under the applied exposure conditions the particles were agglomerated or
aggregated with the size of agglomerates and aggregates in the micrometer range, and were not cytotoxic. TiOz-An, but not
TiOz-Ru, caused a persistent increase in DNA strand breaks (comet assay) and oxidized purines (Fpg-comet). TiOz-An was a
stronger inducer of intracellular reactive oxygen species (ROS) than TiOz-Ru. Both types of TiOz nanoparticles transiently
upregulated mRNA expression of p53 and its downstream regulated DNA damage responsive genes (mdm2, gadd45a, p21),
providing additional evidence that TiOz nanoparticles are genotoxic. The observed differences in responses ofHepGZ cells to
exposure to anatase and rutile TiOz nanoparticles support the evidence that the toxic potential ofTiOz nanoparticles varies not
only with particle size but also with crystalline structure.
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Introduction
The increasing use of nano-sized materials during the
past several years has stimulated investigations of
potential hazards of these useful materials for humans
and environment. One of the most widely used
nanoparticles (NPs) is composed of titanium dioxide
(TiOz); however, most of the titania powder is synthe-
sized from the ore ilmenite, FeTi03 (Greenwood and
Earnshaw 1997). TiOzparticles larger than submicron-
sized (>100 nm) have been classified as biologically
inert in both humans and animals (Chen and Fayer-
weather 1988; Bernard et al. 1990; Hart and Hesterberg
1998) and are widely used as a white pigment in the
production of paints, paper, plastics, ceramics, as a
welding rod coating material and as a food additive
(Nordman and Berlin 1986; Lomer et al. 2002;
Gelis et al. 2003; Gurr et al. 2005). Strong absorption
of UV light makes TiOz a very effective sunscreen for
use in cosmetics (Gelis et al. 2003). Because of its
photocatalytic properties, TiOz is applied in natural
and waste water treatment as a disinfectant (Cho et al.
2004). TiOz finds applications in therapeutic purposes,
being used as a photosensitizer for photodynamic
therapy of endobronchial and esophageal cancers
(Ackroyd et al. 2001). Nowadays, with the rapid devel-
opment and advantages of nanotechnology, NPs of
TiOz (<100 nm) are increasingly replacing their larger
counterparts, predominantly because of their high sta-
bility, anticorrosion and better photocatalytic proper-
ties (Lamer et al. 2002; Gelis et al. 2003; Wang et al.
2007a). However, nanomaterials may differ from the
bulk materials, not only in terms of their desirable
properties but also in terms of their potential adverse
effects.
TiOz NPs can cause oxidative stress-mediated tox-
icity in various tissues and cell types (Zhang and Sun
2004; Gurr et al. 2005; Hussain et al. 2005; Long
et al. 2006; Xia et al. 2006), including DNA damage
(Dunford et al. 1997; Rahman et al. 2002; Gurr et al.
2005; Wang et al. 2007a, 2007b), inflammation
(Borm et al. 2000; Hohr et al. 2002; Warheit et al.
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2006; Grassian et al. 2007), ﬁbrosis (Baggs et al. 1997)
and pulmonary damage (Bermudez et al. 2002, 2004;
Park et al. 2009). Most of the toxicological studies of
TiO2 NPs in mammals have addressed their adverse
effects upon exposure by inhalation and, on this basis
TiO2 has been classiﬁed by the International Agency
for Research on Cancer (IARC) as an IARCGroup 2B
carcinogen “possibly carcinogenic to humans” upon
inhalation (IARC 2006). However, oral ingestion is an
important exposure route for the general population
since TiO2 is used as a food additive, in food contact
materials, in toothpaste, capsules, etc. A literature
survey revealed only one toxicokinetic study on oral
exposure to TiO2 NPs. TiO2 NPs administered as
single high-dose gavage (5 g/kg bw) to mice were
shown to accumulate predominantly in the liver and
spleen, while pathological changes were observed in
kidney, liver and heart, along with changes in serum
biochemical parameters such as increased lactate dehy-
drogenase and a-hydroxybutyrate dehydrogenase
levels (Wang et al. 2007a). A recent study on the tissue
distribution of intravenously (5 mg/kg body weight)
administered TiO2 NPs (>10 wt. % less than 100 nm
size) to rats showed their highest levels on day one in all
organs. The elevated TiO2 levels were retained in the
liver for 28 days, in the spleen there was a slight
decrease in TiO2 levels from day 1 to days 14 and
28, and in the lung and kidney the levels returned to
control levels by day 14. There were no detectable
levels of TiO2 in blood cells, plasma, brain, or lymph
nodes and there were also no obvious toxic health
effects, no immune response, and no change in organ
function (Fabian et al. 2008).
The toxicokinetic studies indicated that liver
appears to be the target of NP toxicity; therefore,
we have applied the experimental model with human
hepatoma HepG2 cells to evaluate the genotoxic
potential of TiO2 NPs. It has been shown that the
biological activities of NPs depend on their physico-
chemical properties (such as size and crystalline struc-
ture), therefore genotoxicity of two types of TiO2
NPs: <25 nm anatase TiO2 particles (TiO2-An)
and <100 nm rutile TiO2 particles (TiO2-Ru) has
been studied. By means of comet assay and its mod-
iﬁed version with lesion speciﬁc DNA repair enzymes
formamidopyrimidine-DNA glycosylase (Fpg) and
endonuclease III (Endo III) that convert oxidized
purines and pyrimidines to AP sites and strand
breaks, respectively (Collins et al. 1996), we deter-
mined TiO2 NPs induction of DNA strand breaks
and oxidative DNA damage. In addition we investi-
gated the effect of TiO2 NPs on mRNA expression
of tumor suppressor gene p53 and its downstream
regulated DNA damage responsive genes, the cyclin-
dependent kinase (CDK) inhibitor p21, the E3
ubiquitin ligase mdm2, and the growth arrest and
DNA damage-inducible gene gadd45a.
Materials and methods
Chemicals
EagleMinimal Essential Medium (EMEM), penicillin/
streptomycin, L-glutamine, phosphate buffered saline
(PBS), trypsin, fetal bovine serum, non-essential amino
acid solution (100), MTT (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide), tert-butyl
hydroperoxide (t-BOOH), benzo(a)pyrene (BaP),
ethidium-bromide solution, 2,7-dichloroﬂuorescein
diacetate (DCFH-DA), dimethyl sulfoxide (DMSO)
were obtained from Sigma-Aldrich (St Louis, MO,
USA). TRIzol was from Invitrogen (Carlsbad, USA),
and cDNA High Capacity Archive Kit, TaqMan
Universal PCRMasterMix andTaqmanGeneExpres-
sion Assays from Applied Biosystems (Foster City,
USA). Normal melting-point (NMP) agarose and
low melting-point agarose (LMP) were from Gibco
BRL (Paisley, Scotland, UK). Enzymes Fpg and
EndoIIIwereagift fromDrAndrewR.Collins (Depart-
ment of Nutrition, University of Oslo, Oslo, Norway).
Characteristics of TiO2 nanoparticles
Two grades of TiO2 powder with different average
particles size (d <25 nm and d <100 nm) and crystalline
structure (anatase and rutile) used in this study were
obtained from Sigma-Aldrich (St Louis, MO, USA).
We denoted them as TiO2-An (Cat. no. 637254: ana-
tase; particle size<25nm;99.7%tracemetalsbasis) and
TiO2-Ru (Cat. no. 637262: rutile; particle size ~ 10 
40 nm; 99.5% tracemetals basis). Their size, crystalline
structure, speciﬁc surface area and aggregation or
agglomeration were conﬁrmed experimentally.
The size and morphology of TiO2 NPs were
observed by ﬁeld-emission-gun scanning electron
microscopy (FEG-SEM) JEOL 7600 F. The powder
samples for the examination were coated with carbon
(SCD 50 sputter coater). The crystal phase of the
powders was identiﬁed by X-ray diffraction (XRD),
using a Philips PW 1050 diffractometer with Cu-KC1,2
radiation (Ni ﬁlter). Measurements were made in the
range of 22 = 8–80 with scanning step width of 0.05
and time steps of 2s. UV/Vis (diffuse reﬂectance)
spectroscopic characterization of the samples was
recorded on GBC Cintra UV-Vis Spectrophotometer
in the wavelength range of 200–800 nm. The speciﬁc
surface area was determined by gas adsorption using
the BET method (Gemini 2370, Micromeritics).
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Particle size distribution of TiO2 NPs in the treat-
ment medium was measured by laser scattering,
using a particle size distribution analyzer Horiba
LA-920 (Japan). The particles were dispersed in
EMEM medium at 30 mg/ml and sonicated using
the same conditions as for preparation of particle
suspensions for the cell treatments.
TiO2 particles, stock solution and treatment media
preparation
Powdered TiO2 NPs were suspended in PBS at a
concentration 1 mg/ml and sonicated for 30 min in
an ultrasonic bath (Sonorex, Bandelin electronic,
Germany) at a frequency of 60 kHz, voltage of
220 V and an electric current of 0.5 A to ensure
uniform suspension. This stock solution was subse-
quently diluted in the complete cell growth medium to
yield concentrations ranging from 1–250 mg/ml. These
samples were then sonicated for 30 min to produce a
stable, less-agglomerated nanocrystalline suspension
before exposure of cells in culture.
Cell culture
HepG2 cells were obtained from European Collection
ofCellCultures (ECACC).CellsweregrowninEMEM
containing 10% fetal bovine serum, 1% non-essential
amino acid solution, 2 mML-glutamine and 100 U/ml
penicillin plus 100 mg/ml streptomycin at 37C in a
humidiﬁed atmosphere with 5% CO2.
Cytotoxicity assay
Cytotoxicity was determined with the MTT assay
according to Mossman (1983) with minor modiﬁca-
tions (Zegura et al. 2003). This assay measures the
conversion of MTT to insoluble formazan by dehy-
drogenase enzymes of intact mitochondria of living
cells. The HepG2 cells were seeded onto 96-well
microplates (Nunc, Naperville, IL, USA) at a density
of 40,000 cells/ml and incubated for 20 h at 37C to
attach. The medium was then replaced by fresh com-
plete medium containing 0, 1, 10, 100 and 250 mg/ml
of TiO2 NPs, and incubated for 4, 24 and 48 h. In each
experiment a vehicle control (cell growth medium
containing 10% PBS) was included. MTT (ﬁnal con-
centration 0.5 mg/ml) was then added, incubated for
an additional 3 h, the medium with MTT was then
removed and the formed formazan crystals dissolved in
DMSO. The optical density (OD) was measured at
570 nm (reference ﬁlter 690 nm) using a microplate
reading spectroﬂuorimeter (Tecan GENios, Austria).
Viability was determined by comparing the OD of the
wells containing the NPs treated cells with those of the
vehicle (cell growth medium containing 10% PBS)
treated cells. Five replicates per concentration point
and three independent experiments were performed.
Intracellular ROS formation – DCFH-DA assay
The formation of intracellular ROS was measured
using a ﬂuorescent probe, DCFH-DA, as described
by Osseni et al. (1999), with minor modiﬁcations
(Zegura et al. 2004). DCFH-DA readily diffuses
through the cell membrane and is hydrolyzed by intra-
cellular esterases to non-ﬂuorescent 2¢,7¢-dichloro-
ﬂuorescein (DCFH) which, in the presence of ROS,
is rapidly oxidized to highly ﬂuorescent 2¢,7¢-dichloro-
ﬂuorescein (DCF). The DCF ﬂuorescence intensity is
proportional to the amount of ROS formed intracel-
lularly. H2O2 is the principle ROS responsible for the
oxidation of DCFH-DA to DCF (LeBel et al. 1992).
The cells were seeded into 96-well, black, tissue
culture treated microtiter plates (Nunc, Naperville,
IL, USA) at a density of 75,000 cells/ml. After 20 h
incubation at 37C in 5% CO2 the cells were loaded
with 20 mM DCFH-DA for 30 min, DCFH-DA was
then removed, and cells treated with 0, 1, 10, 100 and
250 mg/ml of TiO2NPs in PBS. Negative (non-treated
cells) and positive (0.5 mM t-BOOH) controls were
included in each experiment. For kinetic analysis of
ROS formation the plates were maintained at 37C
and the ﬂuorescence intensity (485 nm excitation/
530 nm emission wavelengths) of the formed DCF
recorded every 30 min during the 5 h incubation,
using a microplate reading spectroﬂuorimeter (Tecan,
Genios, Austria). Statistical signiﬁcance between trea-
ted groups and controls was determined by two-
tailed Student’s t-test and P < 0.05 was considered
as statistically signiﬁcant. Three independent experi-
ments with ﬁve replicates were performed.
Comet assay
HepG2 cells were seeded at a density of
» 60,000 cells/ml into 12-well microtiter plates (Corn-
ing Costar Corporation, Corning, NY, USA). After
incubating the cells at 37C in 5% CO2 for 20 h to
attach to the plates, the growth medium was replaced
with fresh medium containing 0, 1, 10, 100 and
250 mg/ml TiO2 NPs and incubated for 2, 4 and
24 h. In each experiment positive controls (0.5 mM
t-BOOH and 50 mM BaP) and a vehicle control (cell
growth medium containing 10% PBS) were included.
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At the end of the exposure the cells were harvested
and the DNA damage determined by the protocol
of Singh et al. (1988) with minor modiﬁcations
(Žegura and Filipic 2004). Images of 50 randomly
selected nuclei per experimental point were analyzed
with image analysis software Comet Assay IV (Per-
ceptive Instruments, UK). Three independent experi-
ments were performed for each of the treatment
conditions. The percent of tail DNA was used to
measure the level of DNA damage.
The level of oxidized purines/pyrimidines was
determined with the modiﬁed comet assay as
described by Collins et al. (1996). After the cell lysis
the slides were washed three times for 5 min with
endonuclease buffer (40 mM HEPES-KOH, 0.1 M
KCl, 0.5 mM EDTA, 0.2 mg/ml bovine serum albu-
min, pH 8.0). Fifty microliter aliquots of Fpg/Endo
III solution or enzyme buffer without Fpg/Endo III
were added, covered with a cover glass and incubated
at 37C for 30/45 min. The slides were then processed
as described above.
One-way analysis of variance (ANOVA, Kruskal-
Wallis) was used to analyze the differences between
treatments within each experiment. Dunnet’s test was
used for comparing median values of percentage tail
DNA; P < 0.05 was considered as statistically
signiﬁcant.
mRNA expression analysis
Cells were seeded at a density of 1,000,000 on
T-25 ﬂasks (Corning Costar Corporation, Corning,
NY, USA) and incubated for 20 h at 37C and 5%
CO2 to attach. The growth medium was then replaced
with fresh medium containing 0, 1, 10, and 100 mg/ml
TiO2 NPs and the cells incubated for 4 and 24 h. In
each experiment a positive control (50 mM BaP) and
a vehicle control (cell growth medium containing
10% PBS) were included. Total RNA from the
cells was isolated using TRIzol reagent, and cDNA
synthesized using 2 mg of total RNA and cDNA High
Capacity Archive Kit (Applied Biosystems, CA, USA),
according to the manufacturer’s protocol. Gene
expression of p53, mdm2, gadd45a and p21 was quan-
tiﬁed using real-time quantitative PCR (ABI 7900 HT
Sequence Detection System, Applied Biosystems,
USA). TaqMan Universal PCR Master Mix and the
following Taqman Gene Expression Assays were used
(all from Applied Biosystems): p53 (tumor protein
p53), Hs00153349_m1; mdm2 (Mdm2, ‘transformed
3T3 cell double minute 2’, p53 binding protein gene),
Hs00234753_m1; gadd45a (‘growth arrest and DNA-
damage-inducible gene, alpha’), Hs00169255_m1;
and p21 (‘cyclin-dependent kinase inhibitor 1A’)
Hs00355782_m1. Ampliﬁcation of GAPDH probe
was performed as an internal control. The conditions
for PCR were 50C for 2 min, 95C for 10 min and
40 cycles of 95C for 15 s and 60C for 1min. The data
obtained from Taqman Gene Expression Assays were
analyzed using the ΔΔCt algorithm. Statistical signiﬁ-
cance between treated groups and controls was deter-
mined by two tailed Student’s t-test and P < 0.05 was
considered signiﬁcant. Independent experiments were
performed in duplicate and repeated at least three
times.
Results
Characteristics of TiO2 NPs
The characteristics of the TiO2 nanopowders used in
this study are summarized in Table I. The FEG-SEM
examination of the TiO2 nanopowders (Figures 1A–D)
showed that both powders are aggregated, with
nearly spherical crystallites for the TiO2-An (Figures
1A, 1B) and elongated crystallites for the TiO2-Ru
(Figures 1C, 1D). The apparent average crystallite’s
sizes are in agreement with speciﬁed sizes provided by
the manufacturer, i.e., around 25 nm for TiO2-An
and under 100 nm for the TiO2-Ru, while the aggre-
gates are much larger. The speciﬁc surface area was
determined to be very similar for both powders, i.e.,
129.3 m2/g for TiO2-An and 116.7 m
2/g for TiO2-Ru,
which is well in agreement with the producer’s spe-
ciﬁcations (Table I). XRD conﬁrmed crystalline
structure for both, anatase sample and rutile sample
of the TiO2 NPs (Powder diffraction ﬁles). The X-ray
diffractogram of rutile shows wider range of reﬂection
and higher level of basic line related to X-ray dif-
fractogram of anatase; which is indicating smaller
crystallite size and lower degree of crystallinity of
rutile. When Sherrer’s formula for calculation the
crystallite size was applied, the size of 10 nm was
found for rutile on reﬂection (110) and of 15 nm for
anatase on reﬂection (101). The reﬂectance UV spec-
tra of the samples are in accordance with the reported
values (Tryba 2008).
The particle size distribution determined by laser
scattering particle size distribution analysis showed
that in the medium both types of TiO2 NPs are highly
aggregated and agglomerated with an average size of
aggregates and agglomerate size at the micron level
(TiO2-An: 915 ± 453 nm; TiO2-Ru: 1542 ± 760 nm).
However, the portion of submicron-sized particles
is much lower in the case of the TiO2-An than in
TiO2-Ru (Figure 1E). Micron-sized aggregates and
agglomerates were conﬁrmed also by FEG-SEM
(Figures 1A–D).
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Cytotoxicity of TiO2 NPs
The viability of HepG2 cells exposed to 0, 1, 10,
100 and 250 mg/ml of TiO2-An or TiO2-Ru for 4,
24 and 48 h was not signiﬁcantly affected (data not
shown). Therefore, these concentrations were used in
further experiments.
Induction of intracellular ROS formation
To explore whether the TiO2-An and TiO2-Ru NPs
induced DNA damage is associated with intracellular
ROS formation, we measured the kinetics of their
formation in HepG2 cells (Figure 2). After 5 h expo-
sure, TiO2-An induced a signiﬁcant elevation of
intracellular ROS formation at all applied concentra-
tions, with a two-fold increase over control level at the
highest concentration, while TiO2-Ru induced a
1.4-fold elevation only at the highest concentration
(Figure 2A). Kinetic measurement of the ROS for-
mation during the 5 h exposure showed that the level
of TiO2-An induced ROS increased steadily over the
control level, while TiO2-Ru induced an increase in
the ROS level during the ﬁrst 90-min exposure, which
afterwards increased at the same rate as the control
(Figure 2B).
Induction of DNA strand breaks and oxidative DNA
damage
In HepG2 cells exposed to TiO2-An NPs we detected
slight, however statistically signiﬁcant (P < 0.05)
greater amount of DNA strand breaks than in the
control, as shown using the comet assay (Figure 3).
The greater amount of DNA damage was observed at
the highest concentration (250 mg/ml) after 2, 4 and
24 h exposure and after 4 h exposure also at 1 mg/ml.
Exposure to TiO2-Ru particles induced signiﬁcantly
more strand breaks only in cells exposed for 4 h to
100 mg/ml TiO2-Ru.
The induction of oxidative DNA damage was stud-
ied with the modiﬁed comet assay with puriﬁed DNA
damage speciﬁc enzymes, Fpg and Endo III, which
recognize and excise oxidized purines and pyrimi-
dines, respectively. The increase of % tail DNA in
enzyme treated slides compared to buffer treated thus
reﬂects the amount of oxidized nucleic bases.
In cells exposed to TiO2-An we observed a signif-
icant dose-dependent increase of Fpg-sensitive sites at
concentrations 10, 100 and 250 mg/ml after 2, 4 and
24 h (Figure 4A). The highest levels of Fpg-sensitive
sites were observed after 4 h exposure at concentra-
tions of 100 and 250 mg/ml, which declined slightly
after 24 h exposure, but remained signiﬁcantly dif-
ferent from the control at concentrations 10, 100 and
250 mg/ml. In cells exposed to TiO2-Ru a signiﬁ-
cant increase of Fpg-sensitive sites was detected
only after 24 h exposure to 10 and 100 mg/ml NPs
(Figure 4B).
Induction of Endo III-sensitive sites by TiO2 NPs
was much lower than that of Fpg-sensitive sites and
was not dose-dependent. After 2 h exposure to TiO2-
An, the increase of Endo III-sensitive sites was sig-
niﬁcant at the highest concentration (250 mg/ml), after
4 h of exposure at a concentration 100 mg/ml, and
after 24 h of exposure at 10 mg/ml (Figure 5A). In
cells exposed to TiO2-Ru, we observed a signiﬁcant
Table I. Characteristics of the TiO2 powders used in this study.
Anatase TiO2-An Rutile TiO2-Ru
Supplier information
(Sigma-Aldrich)
Nanopowder, anatase crystalline structure,
particle size <25 nm, surface area 200–220 m2/g
Nanopowder, rutile crystalline
structure, particle size ~10 nm  40 nm,
surface area 130–190 m2/g
Measurements of speciﬁc
surface area (BET)
129.3 m2/g 116.7 m2/g
FEG-SEM (supplied material)
Particle size within the
agglomerates/aggregates
Particle shape
<25 nm
Spherical crystallites
<100 nm
Elongated crystallites
XRD Anatase type: tetragonal crystallographic
system; I41/amd space group (according
to JCPDS: 21–1272); characteristic
reﬂections (101) at 25.3; (200) at 48.0, 2q
Rutile type: tetragonal crystallographic
system; P42/mnm space group (according
to JCPDS: 34–0180); characteristic
reﬂections (110) at 27.3; (101) at
36.0; (211) at 54.1, 2q.
UV-Vis spectroscopy Anatase: absorption peaks at lmax = 300 nm
and lmax = 210 nm
Rutile: absorption peaks at lmax = 305 nm
and lmax = 205 nm
FEG-SEM, ﬁeld-emission-gun scanning electron microscope; XRD, X-ray diffraction; UV-Vis, ultraviolet- visible spectroscopy.
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increase of Endo III-sensitive sites at the highest
concentration (250 mg/ml) after 2 h and after 24 h
exposure (Figure 5B).
Effect of TiO2 NPs on the expression of DNA damage
responsive genes
The mRNA expression of selected DNA damage
responsive genes was analyzed after 4 h and 24 h
exposure of HepG2 cells to 0, 1, 10 and 100 mg/ml of
TiO2-An and TiO2-Ru by quantitative real-time PCR
(Figure 6).
In cells exposed to TiO2-An for 4 h (Figure 6A), the
mRNA expression of p53 was signiﬁcantly greater
than that of the control cells (P < 0.05) at the
highest concentration (100 mg/ml). Under the same
conditions, expression ofmdm2, p21 and gadd45awas
not affected. After 24 h of exposure to TiO2-An, the
level of p53 mRNA expression remained unchanged.
The expression of p21 and mdm2 was signiﬁcantly
elevated at the highest concentration, while expres-
sion of gadd45a was signiﬁcantly elevated at 10 and
100 mg/ml (Figure 6B).
In cells exposed to TiO2-Ru the expression of p53,
mdm2, p21 and gadd45a after 4 h was signiﬁcantly
elevated at the highest concentration (100 mg/ml)
(Figure 6C). After 24 h exposure to TiO2-Ru, the
expressions of p21, mdm2 and gadd45a were signiﬁ-
cantly elevated at 10 and 100 mg/ml, while the expres-
sion of p53 remained unchanged (Figure 6D).
As the positive control of the test system, we used
50 mM BaP. Exposure of HepG2 cells to BaP for 4 h
did not affect expression of p53, mdm2, p21 and
A. B.
C. D.
E. 15
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Figure 1. FEG-SEM images of the TiO2-An (A, B) and TiO2-Ru (C, D) NPs; Particle size distributions of TiO2-An and TiO2-Ru (E).
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gadd45a, whereas after 24 h exposure BaP induced
14-fold increase of the expression of p21 and six-fold
increase of the gadd45a, while the expression ofmdm2
and p53was not affected (data not shown). These data
conﬁrmed expected responsiveness of the system with
HepG2 cells.
Discussion and conclusion
In this study, we have shown that in HepG2 cells
genotoxic potential of TiO2 NPs varies with particle
size and crystalline structure. Neither TiO2-An nor
TiO2-Ru affected the viability of HepG2 cells, which
is in line with the recent report of Wagner et al.
(2009). On the other hand, both types of TiO2 NPs
induced intracellular ROS formation, DNA strand
breaks and oxidative DNA damage with TiO2-An
being signiﬁcantly stronger inducer than TiO2-Ru.
For the ﬁrst time we showed that exposure to TiO2
NPs induced changes in the mRNA expression of
DNA damage responsive genes, which is character-
istic for genotoxic agents.
The TiO2 powders used in this study differ in
particles size as well as in crystalline structure, which
could both contribute to the observed differences
in their effects. As presented in Figures 1A–E, the
particles are highly aggregated and agglomerated,
which is in line with a number of previous studies
(Limbach et al. 2005; Xia et al. 2006; Falck et al.
2009), and portion of submicron-sized agglomerates
in TiO2-An is much lower than in TiO2-Ru. This
implies that the observed more pronounced effects of
the TiO2-An could be partly ascribed to a higher
concentration of the small particles. However, in
our opinion supported by literature data, the role of
crystalline structure can not be excluded.
For particles with low solubility, such as TiO2, their
capacity to produce ROS is generally proposed to
account for their genotoxicity (Schins 2002; Schins
and Knaapen 2007). In our experiments we con-
ﬁrmed that both types of TiO2 NPs induced intracel-
lular ROS formation, which is in agreement with
other reports describing ROS induction in bronchial
epithelial cells (Gurr et al. 2005; Hussain et al. 2009),
lung epithelial cells (Limbach et al. 2005), and also
brain microglia (Long et al. 2006). We also observed
that the TiO2-An was signiﬁcantly stronger ROS
inducer than TiO2-Ru, which corroborates the results
of Jiang et al. (2008). The difference in the intrinsic
ability of anatase and rutile TiO2 to induce ROS has
been shown to be related to differences in their surface
chemistry (Selloni et al. 1998; Vittadini et al. 1998).
TiO2-An caused weak, however at all exposure
times persistent increase in DNA strand breaks, and
persistent dose-dependent increase in Fpg-sensitive
sites, whereas TiO2-Ru was practically ineffective
(Figure 4). Similar observations have been reported
in several previous studies (Gurr et al. 2005; Reeves
et al. 2008; Zhu et al. 2009). The fact that TiO2-
An induced signiﬁcant increase in the level of Fpg-
sensitive sites, while Endo III-sensitive sites remained
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Figure 2. TiO2-An and TiO2-Ru NPs-induced intracellular ROS formation in HepG2 cells. (A) Induction of ROS formation presented as
relative increase of DCF ﬂuorescence after 5 h exposure to TiO2NPs, (B) kinetics of ROS formation during the 5 h exposure to 250 mg/ml TiO2
NPs. The HepG2 cells loaded with DCFH-DA (20 mM/30 min) were exposed to graded doses of TiO2-An and TiO2-Ru NPs. DCF
ﬂuorescence intensity was measured at 30 min intervals during the 5 h incubation. (A) Each bar represent means (±SD) of three independent
experiments, (B) each point represents the mean of ﬁve replicates (±SD) of representative experiment. (*) denotes a signiﬁcant difference
between TiO2 NPs-treated groups and control (Student’s t-test, P < 0.05).
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unchanged suggests that product of TiO2-induced
oxidative DNA damage is 8-hydroxyguanine (8-OH-
Gua), although formamidopyrimidines (imidazole
ring-opened purines) are also possible substrate for
Fpg (Kielbassa et al. 1997). 8-OH-Gua adducts in
DNA lead to GC ! TA transversion mutations,
unless repaired prior to DNA replication (Grollman
and Moriya 1993; Olinski et al. 2002). Therefore,
persistence of oxidized purines in cells may lead to
mutations and cancer (Valko et al. 2006).
Toxicogenomics, the application of expression
proﬁling in toxicological studies, has the potential
to allow deeper understanding of the mechanisms
of toxicity and can also provide an early and global
answer to toxic events (Brown and Botstein 1999;
Kolaja and Kramer 2002; Ulrich and Friend 2002;
Ellinger-Ziegelbauer et al. 2005). In our study we
have measured changes in the expression of four
genes that are involved in response to DNA damage:
p53 and its downstream targets p21, gadd45a, and
mdm2. p53 tumor suppressor is considered to be
the major sensor of genotoxic stress and is the link
between DNA damage, cell cycle arrest and apoptosis
(Levine 1997). The up-regulation of p53 gene after
exposure to TiO2-An and TiO2-Ru was short-term.
On the transcription level this is not unusual, as it is
known that DNA damage activates the p53 protein,
predominantly through its phosphorylation by DNA
damage responsive kinases and, to a lesser extent,
through up-regulation of gene expression (Zhou and
Elledge 2000). Recently it has been reported that
exposure of peripheral blood lymphocytes to TiO2
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Figure 3. DNA strand break induction by TiO2-An (A) and TiO2-Ru (B) in HepG2 cells. The cells were treated for 2, 4 and 24 h with TiO2
NPs (0, 1, 10, 100, 250 mg/ml). 0.5 mM t-BOOHwas used as positive control for 2 and 4 h treatments and 50 mMBaP for 24 h treatments. The
DNAdamage was assessed using the comet assay as described inMaterials and methods, and is expressed as% of DNA in the tail. Fifty cells were
analyzed per experimental point in each of the three independent experiments. Data are presented as quantile box plots. The edges of the box
represent the 25th and 75th percentiles, the median is a solid line through the box, mean values are represented as square (+), and the error bars
represent the 95% conﬁdence intervals. *P < 0.05 and ***P < 0.001 denotes a signiﬁcant difference between TiO2 NPs-treated and control
groups using ANOVA, Kruskal-Wallis with Dunnet’s post test.
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NPs (70–85% anatase/15–30% rutile) caused accu-
mulation of p53 protein together with intracellular
ROS generation, DNA damage and micronuclei for-
mation (Kang et al. 2008). Under normal conditions
the function of p53 is tightly regulated by its interac-
tion with MDM2, an E3 ubiquitin ligase, which
mediates ubiquitination of p53 and its proteosome-
dependent degradation (Vogelstein et al. 2000).
Expression of mdm2 gene is itself regulated with an
autoregulatory loop in which p53 positively regulates
mdm2 expression while MDM2 protein negatively
regulates p53 levels and activity (Wu et al. 1993).
Both types of TiO2 NPs induced increased expression
of mdm2 gene, although TiO2-Ru was the stronger.
Ellinger-Ziegelbauer et al. (2005), who compared the
proﬁles of gene expression induced by genotoxic and
non-genotoxic carcinogens in rat liver, found that
mdm2 was speciﬁcally up-regulated by genotoxic
carcinogens. Up-regulation of mdm2 has been
detected also after exposure of HepG2 cells to micro-
cystine-LR, for which it has been shown to induce
DNA damage via ROS formation (Zegura et al. 2008).
Following DNA damage, the growth arrest and DNA
damage gene gadd45a plays a role in controlling the
cell cycle G2–M checkpoint, the DNA repair process
and apoptosis (Zhan 2005). Induction of gadd45a is
directly transcriptionally regulated by p53 and it has
been reported to be associated with the oxidative
stress-induced pathway (Wang et al. 1999). The
gadd45a gene has been observed to be induced in
response to a wide range of genotoxic agents, includ-
ing BaP (Akerman et al. 2004), mitomycin C
(Abbas et al. 2002), cisplatin (Smith et al. 1996),
H2O2 (Fornace et al. 1988), microcystin-LR
(Zegura et al. 2008), and organophosphorous pesti-
cides (Hreljac et al. 2008). Signiﬁcantly elevated
80 2 h
***
***
***
***
***
***
***
***
***
*
*
***
***
***
***
***
***
***
******
****
*
**
**
*
4 h 24 h
60
40
20
%
 ta
il D
NA
0
C 1 10 100 250 PC C 1 10
TiO2-An (μg/ml)
100 250 PC C 1 10 100 250 PC
80 2 h 4 h 24 h
60
40
20
%
 ta
il D
NA
0
C 1 10 100 250 PC C 1 10 100 250 PC C 1 10 100 250 PC
B.
A.
Buffer
Fpg
TiO2-Ru (μg/ml)
Figure 4. Induction of Fpg sensitive sites by TiO2-An (A) and TiO2-Ru (B) in HepG2 cells. The cells were exposed to TiO2 NPs (0, 1, 10,
100 and 250 mg/ml) for 2, 4 and 24 h, then the modiﬁed comet assay was performed as described inMaterials and methods. The levels of DNA
strand breaks and oxidized purines are expressed as percent of tail DNA. Fifty cells were analyzed per experimental point in each of the two
independent experiments. Data are presented as quantile box plots (for details see the caption of Figure 3). *P < 0.05, **P < 0.01 and
***P < 0.001 denotes a signiﬁcant difference between TiO2NPs-treated and control groups with and without Fpg, respectively, using ANOVA,
Kruskal-Wallis with Dunnet’s post test.
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expression of gadd45a was induced by both types
of TiO2 NPs after 4 h and 24 h exposure, with
TiO2-Ru being the stronger inducer. Another p53
target is p21, a cyclin-dependent kinase inhibitor,
which is responsible for cell cycle arrest following
DNA damage (Waldman et al. 1995). TiO2-Ru
induced p21 mRNA expression more strongly than
TiO2-An, as was observed also with mdm2 and
gadd45a. Ellinger-Ziegelbauer et al. (2005) found
that, in rat liver, p21 was exclusively up-regulated by
genotoxic carcinogens.
Exposure of HepG2 cells to TiO2-Ru NPs induced
earlier and higher up-regulation of DNA damage
responsive genes than exposure to TiO2-An NPs.
This appears to contradict the higher DNA damaging
potential of TiO2-An NPs observed with the comet
assay. However, up-regulation of DNA damage
responsive genes in fact reﬂects a cellular defense
response against the consequences of DNA damage.
Thus one possible explanation is that, in the cells
exposed to TiO2-Ru NPs, only marginal DNA dam-
age was observed, because the early defense response
triggered repair processes that eliminated the DNA
damage before it could be detected with the comet
assay.
In conclusion, exposure of HepG2 cells to TiO2
NPs did not affect their viability, but induced
increase in oxidative DNA damage, which was asso-
ciated with intracellular ROS production. Exposure
to TiO2 NPs induced changes in the mRNA expres-
sion of p53 and its downstream regulated DNA
damage responsive genes p21, gadd45a and mdm2,
providing additional evidence that TiO2 NPs are
genotoxic. The observed differences in the responses
of HepG2 cells to exposure to TiO2-An and TiO2-
Ru NPs supports evidence that the toxic potential of
TiO2 NPs depends not only on the size, but also on
the crystalline structure.
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Figure 5. Induction of Endo III-sensitive sites by TiO2-An (A) and TiO2-Ru (B) in HepG2 cells. The cells were exposed to TiO2NPs (0, 1, 10,
100 and 250 mg/ml) for 2, 4 and 24 h, then the modiﬁed comet assay was performed as described inMaterials and methods. The levels of DNA
strand breaks and oxidized pyrimidines are expressed as percent of tail DNA. Fifty cells were analyzed per experimental point in each of the two
independent experiments. Data are presented as quantile box plots (for details see the caption of Figure 3). *P < 0.05, **P < 0.01 and
***P < 0.001 denotes a signiﬁcant difference between TiO2 NPs-treated and control groups with and without Endo III, respectively, using
ANOVA, Kruskal-Wallis with Dunnet’s post test.
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